This is a Validated Antibody Database (VAD) review about rhesus mac.. NCAM1, based on 89 published articles (read how Labome selects the articles), using NCAM1 antibody in all methods. It is aimed to help Labome visitors find the most suited NCAM1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Knockout validation
BioLegend
mouse monoclonal (HCD56)
  • immunocytochemistry knockout validation; human; 1:100; loading ...; fig 5e
BioLegend NCAM1 antibody (Biolegend, 318314) was used in immunocytochemistry knockout validation on human samples at 1:100 (fig 5e). elife (2020) ncbi
BioLegend
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 3e
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 3e). J Immunother Cancer (2021) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples . Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 3b
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig s1). Front Immunol (2020) ncbi
mouse monoclonal (HCD56)
  • other; mouse
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in other on mouse samples . Nat Commun (2020) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:100; loading ...; fig 1s1e
BioLegend NCAM1 antibody (Biolegend, 318332) was used in flow cytometry on human samples at 1:100 (fig 1s1e). elife (2020) ncbi
mouse monoclonal (HCD56)
  • other; human; 1:100; loading ...
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in other on human samples at 1:100. elife (2020) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:100; loading ...; fig 1b, 2e, 7b
BioLegend NCAM1 antibody (Biolegend, 318328) was used in flow cytometry on human samples at 1:100 (fig 1b, 2e, 7b). elife (2020) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s2
BioLegend NCAM1 antibody (Biolegend, 318348) was used in flow cytometry on human samples (fig s2). Cell (2020) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1a
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s1a). JCI Insight (2020) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 4b
BioLegend NCAM1 antibody (BioLegend, 318328) was used in flow cytometry on human samples (fig 4b). Stem Cell Reports (2020) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s2o
BioLegend NCAM1 antibody (Biolegend, 318318) was used in flow cytometry on human samples (fig s2o). JCI Insight (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s3
BioLegend NCAM1 antibody (BioLegend, 318303) was used in flow cytometry on human samples (fig s3). Stem Cell Res Ther (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig ex1
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig ex1). Nature (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1f
  • immunocytochemistry; human; loading ...; fig 1g
BioLegend NCAM1 antibody (BioLegend, 318306) was used in flow cytometry on human samples (fig 1f) and in immunocytochemistry on human samples (fig 1g). J Exp Med (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1a
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 1a). Front Immunol (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:100; loading ...; fig s1a, s3b
BioLegend NCAM1 antibody (Biolegend, 318336) was used in flow cytometry on human samples at 1:100 (fig s1a, s3b). Cancer Cell (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 2 ug/ml; loading ...; fig s13
BioLegend NCAM1 antibody (BioLegend, 318305) was used in flow cytometry on human samples at 2 ug/ml (fig s13). Science (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1a
BioLegend NCAM1 antibody (BioLegend, 318322) was used in flow cytometry on human samples (fig 1a). Sci Rep (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 2a
BioLegend NCAM1 antibody (Biolegend, 318317) was used in flow cytometry on human samples (fig 2a). elife (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1a
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s1a). Aging (Albany NY) (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1b
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 1b). Cell Stem Cell (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s3
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s3). PLoS Pathog (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s3
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig s3). J Infect Dis (2019) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 4a
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 4a). J Immunol (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1a, 5b
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 1a, 5b). Front Immunol (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 4a
BioLegend NCAM1 antibody (Biolegend, 318332) was used in flow cytometry on human samples (fig 4a). Stem Cell Reports (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 2a
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 2a). J Cell Biol (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; mouse; 1:60; loading ...; fig 7a
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on mouse samples at 1:60 (fig 7a). J Virol (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; rhesus macaque; loading ...; fig 1b
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on rhesus macaque samples (fig 1b). AIDS (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 3a
BioLegend NCAM1 antibody (BioLegend, 318306) was used in flow cytometry on human samples (fig 3a). Biol Reprod (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig e1b
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig e1b). J Allergy Clin Immunol (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 5j
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 5j). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 1a
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 1a). Immun Inflamm Dis (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2018) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 6
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 6). PLoS ONE (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 1a
In order to study the involvement of Notch signaling in NK cell lineage determination, BioLegend NCAM1 antibody (biolegend, HCD56) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 2e
In order to identify cellular changes induced by IL-2, BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 2e). J Immunol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 4b
In order to evaluate the role of IL-32alpha in NK cell inhibition, BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 4b). J Immunol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s1). J Exp Med (2017) ncbi
mouse monoclonal (SHM14)
  • flow cytometry; human; loading ...; fig 4a
BioLegend NCAM1 antibody (BioLegend, 352702) was used in flow cytometry on human samples (fig 4a). Scand J Immunol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1a
BioLegend NCAM1 antibody (Biolegend, 318310) was used in flow cytometry on human samples (fig 1a). F1000Res (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1
BioLegend NCAM1 antibody (Biolegend, 318310) was used in flow cytometry on human samples (fig 1). PLoS ONE (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1a
In order to determine the localization of FcgammaRI, FcgammaRII, and SIRPalpha in macrophages, BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s1a). J Cell Biol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 1). Clin Exp Immunol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s2a
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples . Clin Immunol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 4b
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BioLegend NCAM1 antibody (Biolegend, 318328) was used in flow cytometry on human samples (fig 4b). Sci Rep (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s2
In order to search for compounds that suppress pro-inflammatory cytokine production in the context of protein kinase C activation, BioLegend NCAM1 antibody (Biolegend, 31805) was used in flow cytometry on human samples (fig s2). Retrovirology (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:20; loading ...; fig 2a
In order to measure CD11d expression on lymphocyte subsets using flow cytometry, BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples at 1:20 (fig 2a). J Leukoc Biol (2017) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 1b
BioLegend NCAM1 antibody (Biolegend, 318340) was used in flow cytometry on human samples (fig 1b). Front Physiol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize CD8 positive alpha beta gamma delta T cells, BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1b
In order to determine which cells express CD83, BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig s1b). J Immunol (2016) ncbi
mouse monoclonal (SHM14)
  • flow cytometry; human; fig 3
BioLegend NCAM1 antibody (Biolegend, 352702) was used in flow cytometry on human samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 1a
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 7
In order to study the functions of WASp knock out natural killer cells, BioLegend NCAM1 antibody (Biolegend, 318334) was used in flow cytometry on human samples (fig 7). Sci Rep (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 1b
In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 1a
In order to assess the effects of platelet-derived ectosomes on natural killer cells, BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • immunocytochemistry; human; loading ...; fig 3a
In order to explore targeting NKA as a means to treat cancer, BioLegend NCAM1 antibody (BioLegend, HCD56) was used in immunocytochemistry on human samples (fig 3a). Mol Ther (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 6a
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 6a). J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 6a
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 6a). J Biol Chem (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
In order to develop an artificial niche to maintain muscle stem cells in a potent and quiescent state, BioLegend NCAM1 antibody (BioLegend, 318319) was used in flow cytometry on human samples . Nat Biotechnol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 6a
BioLegend NCAM1 antibody (Biolegend, 318310) was used in flow cytometry on human samples (fig 6a). J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 2
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 2). J Virol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; mouse; 1:100; fig s2
In order to assess the role of NLRC5 to NK-T-cell crosstalk, BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on mouse samples at 1:100 (fig s2). Nat Commun (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig 3c
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (fig 3c). Clin Cancer Res (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s4a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend NCAM1 antibody (biolegend, HCD56) was used in flow cytometry on human samples (fig s4a). J Immunol (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig s1
In order to describe a highly sensitive microfluidic assay to detect acute myeloid leukemia, BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig s1). Analyst (2016) ncbi
mouse monoclonal (SHM14)
  • flow cytometry; human; fig 2
BioLegend NCAM1 antibody (BioLegend, SHM14) was used in flow cytometry on human samples (fig 2). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; fig s1b
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig s1b). J Immunol (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:200; fig s3
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples at 1:200 (fig s3). Nat Commun (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:200
In order to develop a system to determine human DC development and differentiation, BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples at 1:200. J Immunol Methods (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend NCAM1 antibody (Biolegend, 318332) was used in flow cytometry on human samples . Blood Cancer J (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend NCAM1 antibody (BioLegend, 318331) was used in flow cytometry on human samples . J Exp Med (2015) ncbi
mouse monoclonal (HCD56)
  • immunocytochemistry; roundworm
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BioLegend NCAM1 antibody (Biolegend, clone HCD56) was used in immunocytochemistry on roundworm samples and in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend NCAM1 antibody (BioLegend, HCD 56) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (SHM14)
  • flow cytometry; human
In order to use a multi-omics strategy to elucidate the cellular programs altered by Staphylococcus aureus alpha-toxin, BioLegend NCAM1 antibody (Biolegend, 352704) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 4
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 4). Infect Immun (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 4
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 4). J Exp Med (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; 1:25; fig s1
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples at 1:25 (fig s1). Nat Commun (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human
BioLegend NCAM1 antibody (BioLegend, HCD56) was used in flow cytometry on human samples . Rheumatology (Oxford) (2015) ncbi
mouse monoclonal (HCD56)
  • flow cytometry; human; fig 2
BioLegend NCAM1 antibody (Biolegend, HCD56) was used in flow cytometry on human samples (fig 2). J Infect Dis (2015) ncbi
Invitrogen
mouse monoclonal (TULY56)
  • flow cytometry; human; fig 6a, s11, s12c
Invitrogen NCAM1 antibody (eBiosciences, 17-0566-42) was used in flow cytometry on human samples (fig 6a, s11, s12c). Nat Commun (2019) ncbi
mouse monoclonal (TULY56)
  • flow cytometry; human; loading ...; fig s2
Invitrogen NCAM1 antibody (eBioscience, 11-0566-42) was used in flow cytometry on human samples (fig s2). BMC Cancer (2019) ncbi
Articles Reviewed
  1. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed publisher
  2. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  3. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  4. Katano I, Ito R, Kawai K, Takahashi T. Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcγR-Deficient Human IL-15 Transgenic Mouse. Front Immunol. 2020;11:532684 pubmed publisher
  5. Tseng H, Xiong W, Badeti S, Yang Y, Ma M, Liu T, et al. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Nat Commun. 2020;11:4810 pubmed publisher
  6. Bennstein S, Weinhold S, Manser A, Scherenschlich N, Noll A, Raba K, et al. Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells. elife. 2020;9: pubmed publisher
  7. Leelatian N, Sinnaeve J, Mistry A, Barone S, Brockman A, Diggins K, et al. Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells. elife. 2020;9: pubmed publisher
  8. Gunesch J, Dixon A, Ebrahim T, Berrien Elliott M, Tatineni S, Kumar T, et al. CD56 regulates human NK cell cytotoxicity through Pyk2. elife. 2020;9: pubmed publisher
  9. Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Moderbacher C, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489-1501.e15 pubmed publisher
  10. Martin E, Minet N, Boschat A, Sanquer S, Sobrino S, Lenoir C, et al. Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation. JCI Insight. 2020;5: pubmed publisher
  11. Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed publisher
  12. Zou F, Lu L, Liu J, Xia B, Zhang W, Hu Q, et al. Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56. Nat Commun. 2019;10:4109 pubmed publisher
  13. Choi J, Lee E, Kim S, Park S, Oh S, Kang J, et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817 pubmed publisher
  14. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  15. Okumura T, Horie Y, Lai C, Lin H, Shoda H, Natsumoto B, et al. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector. Stem Cell Res Ther. 2019;10:185 pubmed publisher
  16. Ardain A, Domingo Gonzalez R, Das S, Kazer S, Howard N, Singh A, et al. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 2019;: pubmed publisher
  17. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  18. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  19. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
  20. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  21. de Jonge K, Ebering A, Nassiri S, Maby El Hajjami H, Ouertatani Sakouhi H, Baumgaertner P, et al. Circulating CD56bright NK cells inversely correlate with survival of melanoma patients. Sci Rep. 2019;9:4487 pubmed publisher
  22. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed publisher
  23. Muller Durovic B, Grählert J, Devine O, Akbar A, Hess C. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging (Albany NY). 2019;11:724-740 pubmed publisher
  24. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  25. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed publisher
  26. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed publisher
  27. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  28. Cooper G, Ostridge K, Khakoo S, Wilkinson T, Staples K. Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. Front Immunol. 2018;9:1671 pubmed publisher
  29. Yang X, Zhou J, He J, Liu J, Wang H, Liu Y, et al. An Immune System-Modified Rat Model for Human Stem Cell Transplantation Research. Stem Cell Reports. 2018;11:514-521 pubmed publisher
  30. Srpan K, Ambrose A, Karampatzakis A, Saeed M, Cartwright A, Guldevall K, et al. Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells. J Cell Biol. 2018;217:3267-3283 pubmed publisher
  31. Kiener R, Fleischmann M, Wiegand M, Lemmermann N, Schwegler C, Kaufmann C, et al. Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors. J Virol. 2018;92: pubmed publisher
  32. Manickam C, Nwanze C, Ram D, Shah S, Smith S, Jones R, et al. Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract. AIDS. 2018;32:1571-1578 pubmed publisher
  33. Warthan M, Washington S, Franzese S, Ramus R, Kim K, York T, et al. The role of endoplasmic reticulum aminopeptidase 2 in modulating immune detection of choriocarcinoma. Biol Reprod. 2018;98:309-322 pubmed publisher
  34. Maric J, Ravindran A, Mazzurana L, Björklund Ã, Van Acker A, Rao A, et al. Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. 2018;141:1761-1773.e6 pubmed publisher
  35. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  36. Hydes T, Noll A, Salinas Riester G, Abuhilal M, Armstrong T, Hamady Z, et al. IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells. Immun Inflamm Dis. 2018;6:34-46 pubmed publisher
  37. Chan Y, Zuo J, Inman C, Croft W, Begum J, Croudace J, et al. NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. Eur J Immunol. 2018;48:316-329 pubmed publisher
  38. Jackson E, Zhang C, Kiani Z, Lisovsky I, Tallon B, Del Corpo A, et al. HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness. PLoS ONE. 2017;12:e0185160 pubmed publisher
  39. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  40. Jensen H, Potempa M, Gotthardt D, Lanier L. Cutting Edge: IL-2-Induced Expression of the Amino Acid Transporters SLC1A5 and CD98 Is a Prerequisite for NKG2D-Mediated Activation of Human NK Cells. J Immunol. 2017;199:1967-1972 pubmed publisher
  41. Gorvel L, Korenfeld D, Tung T, Klechevsky E. Dendritic Cell-Derived IL-32?: A Novel Inhibitory Cytokine of NK Cell Function. J Immunol. 2017;199:1290-1300 pubmed publisher
  42. Djaoud Z, Guethlein L, Horowitz A, Azzi T, Nemat Gorgani N, Olive D, et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med. 2017;214:1827-1841 pubmed publisher
  43. Pérez Martínez C, Maravillas Montero J, Meza Herrera I, Vences Catalan F, Zlotnik A, Santos Argumedo L. Tspan33 is Expressed in Transitional and Memory B Cells, but is not Responsible for High ADAM10 Expression. Scand J Immunol. 2017;86:23-30 pubmed publisher
  44. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  45. Llibre A, Garner L, Partridge A, Freeman G, Klenerman P, Willberg C. Expression of lectin-like transcript-1 in human tissues. F1000Res. 2016;5:2929 pubmed publisher
  46. Kaczmarek D, Kokordelis P, Kramer B, Glässner A, Wolter F, Goeser F, et al. Alterations of the NK cell pool in HIV/HCV co-infection. PLoS ONE. 2017;12:e0174465 pubmed publisher
  47. Lopes F, Bálint Å, Valvo S, Felce J, Hessel E, Dustin M, et al. Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages. J Cell Biol. 2017;216:1123-1141 pubmed publisher
  48. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed publisher
  49. Jensen H, Chen S, Folkersen L, Nolan G, Lanier L. EBI3 regulates the NK cell response to mouse cytomegalovirus infection. Proc Natl Acad Sci U S A. 2017;114:1625-1630 pubmed publisher
  50. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed publisher
  51. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  52. Spivak A, Larragoite E, Coletti M, Macedo A, Martins L, Bosque A, et al. Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo. Retrovirology. 2016;13:88 pubmed publisher
  53. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed publisher
  54. Ducret M, Fabre H, Degoul O, Atzeni G, McGuckin C, Forraz N, et al. Immunophenotyping Reveals the Diversity of Human Dental Pulp Mesenchymal Stromal Cells In vivo and Their Evolution upon In vitro Amplification. Front Physiol. 2016;7:512 pubmed
  55. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  56. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  57. Lorenzen I, Lokau J, Korpys Y, Oldefest M, Flynn C, Künzel U, et al. Control of ADAM17 activity by regulation of its cellular localisation. Sci Rep. 2016;6:35067 pubmed publisher
  58. Muller Durovic B, Lanna A, Covre L, Mills R, Henson S, Akbar A. Killer Cell Lectin-like Receptor G1 Inhibits NK Cell Function through Activation of Adenosine 5'-Monophosphate-Activated Protein Kinase. J Immunol. 2016;197:2891-2899 pubmed publisher
  59. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed publisher
  60. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
  61. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed publisher
  62. Marshall D, Harried S, Murphy J, Hall C, Shekhani M, Pain C, et al. Extracellular Antibody Drug Conjugates Exploiting the Proximity of Two Proteins. Mol Ther. 2016;24:1760-1770 pubmed publisher
  63. Suliman S, Geldenhuys H, Johnson J, Hughes J, Smit E, Murphy M, et al. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. J Immunol. 2016;197:1100-1110 pubmed publisher
  64. Wittmann A, Lamprinaki D, Bowles K, Katzenellenbogen E, Knirel Y, Whitfield C, et al. Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells. J Biol Chem. 2016;291:17629-38 pubmed publisher
  65. Quarta M, Brett J, DiMarco R, de Morrée A, Boutet S, Chacon R, et al. An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy. Nat Biotechnol. 2016;34:752-9 pubmed publisher
  66. Reches A, Nachmani D, Berhani O, Duev Cohen A, Shreibman D, Ophir Y, et al. HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins. J Immunol. 2016;196:4967-76 pubmed publisher
  67. Offersen R, Nissen S, Rasmussen T, Østergaard L, Denton P, Søgaard O, et al. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells. J Virol. 2016;90:4441-4453 pubmed publisher
  68. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  69. Vallera D, Felices M, McElmurry R, McCullar V, Zhou X, Schmohl J, et al. IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function. Clin Cancer Res. 2016;22:3440-50 pubmed publisher
  70. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  71. Jackson J, Taylor J, Witek M, Hunsucker S, Waugh J, Fedoriw Y, et al. Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood. Analyst. 2016;141:640-51 pubmed publisher
  72. Popov L, Marceau C, Starkl P, Lumb J, Shah J, Guerrera D, et al. The adherens junctions control susceptibility to Staphylococcus aureus α-toxin. Proc Natl Acad Sci U S A. 2015;112:14337-42 pubmed publisher
  73. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  74. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  75. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
  76. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed publisher
  77. Kim S, Theunissen J, Balibalos J, Liao Chan S, Babcock M, Wong T, et al. A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. Blood Cancer J. 2015;5:e316 pubmed publisher
  78. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed publisher
  79. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  80. Zhou J, Amran F, Kramski M, Angelovich T, Elliott J, Hearps A, et al. An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients. J Immunol. 2015;194:4688-97 pubmed publisher
  81. Richter E, Harms M, Ventz K, Gierok P, Chilukoti R, Hildebrandt J, et al. A multi-omics approach identifies key hubs associated with cell type-specific responses of airway epithelial cells to staphylococcal alpha-toxin. PLoS ONE. 2015;10:e0122089 pubmed publisher
  82. Obiero J, Shekalaghe S, Hermsen C, Mpina M, Bijker E, Roestenberg M, et al. Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection. Infect Immun. 2015;83:2185-96 pubmed publisher
  83. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed publisher
  84. Zimmermann M, Aguilera F, Castellucci M, Rossato M, Costa S, Lunardi C, et al. Chromatin remodelling and autocrine TNFα are required for optimal interleukin-6 expression in activated human neutrophils. Nat Commun. 2015;6:6061 pubmed publisher
  85. Renauer P, Coit P, Sawalha A. The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin Immunol. 2015;156:19-27 pubmed publisher
  86. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed publisher
  87. Armour K, Smith C, Ip N, Ellison C, Kirton C, Wilkes A, et al. Clearance of human IgG1-sensitised red blood cells in vivo in humans relates to the in vitro properties of antibodies from alternative cell lines. PLoS ONE. 2014;9:e109463 pubmed publisher
  88. Jansen D, Hameetman M, van Bergen J, Huizinga T, van der Heijde D, Toes R, et al. IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities. Rheumatology (Oxford). 2015;54:728-35 pubmed publisher
  89. Madhavi V, Ana Sosa Batiz F, Jegaskanda S, Center R, Winnall W, Parsons M, et al. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy. J Infect Dis. 2015;211:529-38 pubmed publisher